J0256 Alpha 1 proteinase inhibitor
Also known as: alpha-1 proteinase inhibitor, AAT replacement
Alpha-1 proteinase inhibitor injection, a plasma-derived protein for alpha-1 antitrypsin deficiency.
In Plain Language
lung disease protein treatment; emphysema prevention therapy
Clinical Context
Intravenous plasma-derived or recombinant alpha-1 proteinase inhibitor for alpha-1 antitrypsin deficiency. Prevents progressive emphysema and lung damage.
RVU Information
CPT J0256 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J0256?
CPT J0256 (Alpha 1 proteinase inhibitor) is a J Codes (Drugs) code. Alpha-1 proteinase inhibitor injection, a plasma-derived protein for alpha-1 antitrypsin deficiency.
How is J0256 administered?
CPT J0256 is administered by a healthcare provider, typically via injection or infusion. Intravenous plasma-derived or recombinant alpha-1 proteinase inhibitor for alpha-1 antitrypsin deficiency. Prevents progressive emphysema and lung damage. It is used by Pulmonology, Internal Medicine, Genetics.
When is CPT J0256 used?
Intravenous plasma-derived or recombinant alpha-1 proteinase inhibitor for alpha-1 antitrypsin deficiency. Prevents progressive emphysema and lung damage.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.